Big Risk, Big Rewards in Small Cap Biotech Print
By Staff and Wire Reports   
Thursday, 05 April 2012 05:58
Mark Teper, the managing Partner at Strategic Wealth Partners says there's huge opportunity in the biotech sector. "As wayne gretzky says, you need to skate to where the puck's going, not where it's been," explained Teper in a live interview on CNBC.

"R
ight now the biggest wave that's in front of us is the biotech sector. There's just a ton of companies out there that are really on the verge of some pretty remarkable breakthroughs when it comes to treating the likes of cancer, heart disease, Alzheimer's.

"These advancements are
really going to change our lives over the course of the next several years. What names in particular? If you're looking to hit a home run, stay away from the big boys. Look at really the small cap players. Spectrum Pharmaceuticals. Seattle Genetics. These are all examples of companies that we feel have some pretty good potential as far as the smaller companies go.

Video of Tepper's informative appearance on CNBC appears below:





"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus